Comparison |
| Container Type |
Bottle | | | | |
| Country of Origin |
Ireland | Unknown | Unknown | United States | United States |
| For Use With |
For Architect i1000 and i2000 Analyzer | For BD Viper™ Instrument | For BD Viper™ Instrument | For use on the ACE Axcel and ACE Alera Clinical Chemistry Systems | For use on the ACE Axcel and ACE Alera Clinical Chemistry Systems |
| Number of Tests |
100 Tests | 1,152 Tests | 1,152 Tests | 450 Tests | 450 Tests |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Sample Type |
Human Serum / Plasma Sample | Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Samples | Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Samples | Serum / Plasma Sample | Serum / Plasma Sample |
| Storage Requirements |
Requires Refrigeration | | | Requires Refrigeration | Requires Refrigeration |
| Test Method |
Chemiluminescent Microparticle Immunoassay (CMIA) | Amplified DNA Assay | | | |
| Test Name |
Free Thyroxine (T4) | Chlamydia Trachomatis / Neisseria Gohorrhoeae (CT / NG) | Neisseria Gonorrhoea (NG) | Alanine Aminotransferase (ALT) | Aspartate Aminotransferase (AST) |
| Test Type |
Thyroid / Metabolic Assay | Infectious Disease Immunoassay | DNA Amplification / Detection | Hepatic / General Chemistry | Hepatic / General Chemistry |
| UNSPSC Code |
41116004 | 41116011 | 41116011 | 41116105 | 41116105 |
| Volume |
R1: 6.6 mL, R2: 5.9 mL | 1,152 Tests | | | R1: 3 X 12 mL, R2: 3 X 12 mL |
| Application |
Reagent Kit | Reagent Kit | Reagent Kit | Reagent Kit | Reagent Kit |
| Features and Benefits |
- The ARCHITECT Free T4 (FT4) assay is a Chemiluminescent Microparticle Immunoassay (CMIA) for the quantitative determination of free thyroxine (Free T4) in human serum and plasma
|
- Qualitative detection of Chlamydia trachomatis DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- For the quantitative determination of alanine aminotransferase activity in serum and lithium heparin plasma
|
- For the quantitative determination of aspartate aminotransferase activity in serum and lithium heparin plasma
|
